Show simple item record

dc.contributor.advisorLê, Minh Thông
dc.contributor.authorNguyễn, Phương Nhi
dc.date.accessioned2025-02-17T04:39:25Z
dc.date.available2025-02-17T04:39:25Z
dc.date.issued2024-07
dc.identifier.urihttp://keep.hcmiu.edu.vn:8080/handle/123456789/6680
dc.description.abstractTuberculosis (TB) is the world's 13th leading cause of mortality and the second most transmissible cause of death after COVID-19. Despite the existence of vaccines and therapies, TB remains a significant threat if it is not properly recognized. It affects the respiratory system, causing chronic coughs, chest pain, and coughing up blood or mucus. TB can be categorized as latent TB infection (LTBI) or TB disease, with untreated TB potentially resulting in mortality. Presently, Tuberculosis bacteria are identified by a variety of techniques, including sputum testing using Ziehl stain, culture, X-ray imaging, Mantoux response, or bronchoscopy. Nevertheless, these technologies are not without their limits, including concerns about time and accuracy. The culture method is often regarded as the most reliable and accurate; however, the slow division of Mycobacterium tuberculosis leads to unpredictable findings. Only a small number of level 3 laboratories in Vietnam are authorized to transport tuberculosis bacterial samples solely for research purposes. However, ethical considerations also arise from regularly gathering samples from patients with tuberculosis. PCR, a significant breakthrough in molecular biology, is utilized in biomedical diagnosis to address the aforementioned issues. PCR is highly sensitive, but it is susceptible to many factors that can lead to false positive or false negative results, impacting the accuracy of the diagnosis. Thus, there is a necessity for an approach to provide quality control. TA cloning is another crucial technique that enables the generation of positive controls by inserting DNA segments into a plasmid vector. The IS6110 gene is widely present and frequently used to identify and distinguish Mycoplasma tuberculosis DNA in clinical samples using PCR. Hence, the aim of this research is to enhance the detection of tuberculosis by employing TA cloning methods to construct a plasmid that harbors the IS6110 gene. It will act as a positive control sample, ensuring the quality control of the test and reducing the need for multiple samples. The project aims to lay the foundation in the laboratory for future research focused on improving the sensitivity of TB detection methods. According to the study's findings, the researchers can accurately and efficiently detect tuberculosis with a high level of reliability. Moreover, this study is expected to increase the ability to proactively generate more positive controls for other pathogens in the future.en_US
dc.subjectPCRen_US
dc.subjectdiagnosisen_US
dc.subjectMycoplasma tuberculosisen_US
dc.subjectIS6110en_US
dc.subjectTA cloning techniquesen_US
dc.subjectpositive controlen_US
dc.titleConstruction of plasmid containing IS6110 region of Mycoplasma tuberculosis for using as a Positive control in molecular diagnosticsen_US
dc.typeThesisen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record